Dr Tengku Ahmad Hidayat Tengku K. Aziz, Consultant Clinical Haematologist at Beacon Hospital, says it’s possible to survive and live with multiple myeloma, thanks to breakthroughs in treatment.
Drug therapies are available for multiple myeloma patients who can’t undergo a bone marrow transplant, such as proteasome inhibitors (PIs) or monoclonal antibodies, as well as CAR T-cell therapy and bispecific antibodies.
Dr Tengku Ahmad Hidayat said Malaysia has good access to first-line, second-line, and even third-line treatments for multiple myeloma, but CAR T-cell therapy isn’t widely available here.
Besides the issue of cost of treatment, Dr Tengku Ahmad Hidayat also said there is a lack of haematologists in Malaysia, especially outside urban areas.
For full article, source : CodeBlue
